CDNA vs VCYT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

CDNA

32.0
AI Score
VS
VCYT Wins

VCYT

37.1
AI Score

Investment Advisor Scores

CDNA

32score
Recommendation
AVOID NEW MONEY

VCYT

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CDNA VCYT Winner
Forward P/E 156.25 23.5849 VCYT
PEG Ratio -0.12 0 Tie
Revenue Growth 52.2% 15.5% CDNA
Earnings Growth 0.0% 288.9% VCYT
Tradestie Score 32.0/100 37.1/100 VCYT
Profit Margin 24.2% 20.4% CDNA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

CDNA 1M: +36.1% · 3M: +128.3% VCYT 1M: +3.5% · 3M: -21.2%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81

RSI (14): 80.8 · Price: $66.66

VCYT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.2 · Price: $44.96

Fundamentals Snapshot

Metric CDNA VCYT
Market Cap — —
Forward P/E 51.3 22.7
Trailing P/E 30.8 32.9
Revenue (TTM) — —
Revenue Growth 0.5% 0.2%
Gross Margin 0.7% 0.7%
Operating Margin 0.0% 0.2%
EPS 2.11 1.40
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, VCYT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.